IL110204A0 - Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders - Google Patents
Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disordersInfo
- Publication number
- IL110204A0 IL110204A0 IL11020494A IL11020494A IL110204A0 IL 110204 A0 IL110204 A0 IL 110204A0 IL 11020494 A IL11020494 A IL 11020494A IL 11020494 A IL11020494 A IL 11020494A IL 110204 A0 IL110204 A0 IL 110204A0
- Authority
- IL
- Israel
- Prior art keywords
- novel
- processes
- preparation
- treatment
- cns disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Eyeglasses (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939313913A GB9313913D0 (en) | 1993-07-06 | 1993-07-06 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL110204A0 true IL110204A0 (en) | 1995-01-24 |
Family
ID=10738344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11020494A IL110204A0 (en) | 1993-07-06 | 1994-07-04 | Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders |
Country Status (15)
Country | Link |
---|---|
US (1) | US5834494A (fi) |
EP (1) | EP0707581B1 (fi) |
JP (1) | JPH08512299A (fi) |
CN (1) | CN1129937A (fi) |
AP (1) | AP463A (fi) |
AT (1) | ATE149163T1 (fi) |
AU (1) | AU7228394A (fi) |
CA (1) | CA2166624A1 (fi) |
DE (1) | DE69401823T2 (fi) |
GB (1) | GB9313913D0 (fi) |
IL (1) | IL110204A0 (fi) |
MA (1) | MA23254A1 (fi) |
TW (1) | TW297023B (fi) |
WO (1) | WO1995001976A1 (fi) |
ZA (1) | ZA944807B (fi) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5618824A (en) * | 1994-03-09 | 1997-04-08 | Merrell Pharmaceuticals Inc. | Treatment of obsessive-compulsive disorders with 5-HT2 antagonists |
GB9414139D0 (en) * | 1994-07-13 | 1994-08-31 | Smithkline Beecham Plc | Novel compounds |
GB9420521D0 (en) * | 1994-10-12 | 1994-11-30 | Smithkline Beecham Plc | Novel compounds |
JPH10513443A (ja) * | 1995-02-02 | 1998-12-22 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5HT▲下2c▼レセプターアンタゴニスト活性を有する複素環化合物 |
HU223601B1 (hu) * | 1995-02-02 | 2004-10-28 | Smithkline Beecham P.L.C. | 5-HT receptor antagonista indolszármazékok |
GB9517559D0 (en) * | 1995-08-26 | 1995-10-25 | Smithkline Beecham Plc | Novel compounds |
AU2759597A (en) * | 1996-05-16 | 1997-12-05 | Allelix Biopharmaceuticals Inc. | Thiophene- and furan-tryptamine derivatives |
GB9612885D0 (en) | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
GB9612883D0 (en) * | 1996-06-20 | 1996-08-21 | Smithkline Beecham Plc | Novel compounds |
US6362009B1 (en) | 1997-11-21 | 2002-03-26 | Merck & Co., Inc. | Solid phase synthesis of heterocycles |
FR2778662B1 (fr) * | 1998-05-12 | 2000-06-16 | Adir | Nouveaux composes cycliques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
EP1122252A4 (en) * | 1998-10-16 | 2002-06-26 | Takeda Chemical Industries Ltd | CONDENSED HEREROCYCLIC NITROGEN COMPOUNDS; MANUFACTURING PROCESS AND AGENTS CONTAINING THEM |
US6453357B1 (en) | 1999-01-07 | 2002-09-17 | Cisco Technology, Inc. | Method and system for processing fragments and their out-of-order delivery during address translation |
US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
WO2000076984A2 (en) * | 1999-05-21 | 2000-12-21 | Biovitrum Ab | Novel compounds, their use and preparation |
UA77650C2 (en) | 1999-12-06 | 2007-01-15 | Lundbeck & Co As H | Use of serotonin reuptake inhibitor in combination with deramcyclane |
FR2810979B1 (fr) * | 2000-06-29 | 2002-08-23 | Adir | Nouveaux derives de diphenyluree, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
GB0019950D0 (en) * | 2000-08-12 | 2000-09-27 | Smithkline Beecham Plc | Compounds |
SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
EP1304589A1 (en) * | 2001-07-09 | 2003-04-23 | Alcatel | Connector for optical fibers |
US6861440B2 (en) | 2001-10-26 | 2005-03-01 | Hoffmann-La Roche Inc. | DPP IV inhibitors |
FR2837823B1 (fr) * | 2002-03-27 | 2005-04-08 | Servier Lab | Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
DE60330864D1 (de) | 2002-06-19 | 2010-02-25 | Biovitrum Ab Publ | Neue verbindungen, deren verwendung und herstellung |
EP1638968B1 (en) | 2003-06-20 | 2009-07-29 | F.Hoffmann-La Roche Ag | Hexahydropyridoisoqinolines as dpp-iv inhibitors |
DE602004030244D1 (de) | 2003-06-20 | 2011-01-05 | Hoffmann La Roche | Itoren |
WO2007031508A1 (en) * | 2005-09-13 | 2007-03-22 | Bayer Cropscience Ag | Pesticide phenyloxy substituted phenylamidine derivatives |
US9052304B2 (en) | 2009-03-13 | 2015-06-09 | Terrasep, Llc | Methods and apparatus for centrifugal liquid chromatography |
CN106278987A (zh) * | 2016-08-16 | 2017-01-04 | 都创(上海)医药科技有限公司 | 吲哚啉类化合物的制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4428881A (en) * | 1977-12-23 | 1984-01-31 | Gulf Oil Corporation | Control of unwanted vegetation with N-carbamylindolines |
CA2091246A1 (en) * | 1990-09-13 | 1992-03-14 | Ian Thomson Forbes | Indole ureas as 5 ht receptor antagonist |
JPH08500580A (ja) * | 1992-08-20 | 1996-01-23 | スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー | 5ht▲下2c▼および5ht▲下2b▼拮抗薬用縮合インドール誘導体 |
-
1993
- 1993-07-06 GB GB939313913A patent/GB9313913D0/en active Pending
-
1994
- 1994-06-30 EP EP94921638A patent/EP0707581B1/en not_active Expired - Lifetime
- 1994-06-30 JP JP7503812A patent/JPH08512299A/ja active Pending
- 1994-06-30 CN CN94193185A patent/CN1129937A/zh active Pending
- 1994-06-30 AU AU72283/94A patent/AU7228394A/en not_active Abandoned
- 1994-06-30 WO PCT/EP1994/002148 patent/WO1995001976A1/en active IP Right Grant
- 1994-06-30 AT AT94921638T patent/ATE149163T1/de not_active IP Right Cessation
- 1994-06-30 CA CA002166624A patent/CA2166624A1/en not_active Abandoned
- 1994-06-30 DE DE69401823T patent/DE69401823T2/de not_active Expired - Fee Related
- 1994-07-04 AP APAP/P/1994/000653A patent/AP463A/en active
- 1994-07-04 MA MA23564A patent/MA23254A1/fr unknown
- 1994-07-04 ZA ZA944807A patent/ZA944807B/xx unknown
- 1994-07-04 IL IL11020494A patent/IL110204A0/xx unknown
- 1994-07-05 TW TW083106150A patent/TW297023B/zh active
-
1996
- 1996-09-23 US US08/717,957 patent/US5834494A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0707581B1 (en) | 1997-02-26 |
CN1129937A (zh) | 1996-08-28 |
DE69401823D1 (de) | 1997-04-03 |
MA23254A1 (fr) | 1995-04-01 |
WO1995001976A1 (en) | 1995-01-19 |
DE69401823T2 (de) | 1997-08-28 |
US5834494A (en) | 1998-11-10 |
ZA944807B (en) | 1996-01-04 |
CA2166624A1 (en) | 1995-01-19 |
ATE149163T1 (de) | 1997-03-15 |
EP0707581A1 (en) | 1996-04-24 |
AP463A (en) | 1996-02-19 |
AP9400653A0 (en) | 1994-07-31 |
JPH08512299A (ja) | 1996-12-24 |
GB9313913D0 (en) | 1993-08-18 |
AU7228394A (en) | 1995-02-06 |
TW297023B (fi) | 1997-02-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL110204A0 (en) | Novel indolene derivatives, processes for their preparation and their use for the treatment of cns disorders | |
IL116998A0 (en) | Novel indoline compounds processes for their preparation and their use for the treatment of CNS disorders | |
EP0715851A3 (en) | Substituted phenylpyrimidine derivatives useful in the treatment or prevention of diseases of the central nervous system | |
GB9119504D0 (en) | Process for the preparation of naphtha | |
EP0458333A3 (en) | Polyisocyanato-isocyanurate, and preparation process and use of the same | |
EP0510503A3 (en) | Process for the treatment of surfaces | |
GB9503893D0 (en) | Process for the preparation and purification of iodinated agents | |
KR970000398B1 (en) | Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane | |
GR3018814T3 (en) | Process for the purification of 1,1,1,2-tetrafluoroethane. | |
EP0692476A3 (de) | Verbessertes Verfahren zur Herstellung von N,N'-Carbonyldiazolen, insbesondere N,N'-Carbonyldiimidazol | |
HU9200354D0 (en) | Process for the production of 2-ethyl-4-/2'/-1h-1,2,3,4-tetrazole-5-yl/-biphenyl-4-yl/-metoxi/-kinoline-hydrocloride | |
EP0679397A3 (de) | Verwendung von substituierten Aminen zur Behandlung von Hirnleistungsstörungen. | |
ZA935154B (en) | Use of 1,2,5-oxadiazole-2-oxides for the treatment of erectile dysfunctions | |
EP0570769A3 (en) | Process for the preparation and purification of nitroaromatics | |
EP0628536A3 (de) | Verfahren zur Herstellung von Aminen. | |
EP0557949A3 (en) | Process for the preparation of 2,4,5 trifluorobenzonitrile | |
HU9503959D0 (en) | Process for the preparation of substituted 4,6-diamino-5-cyanopyrimidines | |
EP0507458A3 (en) | Process for the purification of 1,1,1,2-tetrafluoroethane | |
IL100187A0 (en) | Process for the preparation of bromonitro-alcohols,dibromonitro-alcohols and mixtures thereof | |
IL97772A0 (en) | Processes for the manufacture of 2-deoxy-d-threo-pentofuranose derivatives,and 2-deoxy-pentofuranose derivatives | |
ZA936874B (en) | Process for the preparation of 5,6-diacetoxyindole | |
IL104756A0 (en) | Composition for the treatment of glaucoma | |
EP0500083A3 (en) | Process for the preparation of 2,4-dichloro-5-fluorobenzonitrile | |
ZA922624B (en) | Process for the preparation of 2-pyridylsulfonylureas,and thiadiazolopyridines as intermediates in this process | |
GB9307923D0 (en) | Process for the purification of 1-chloro-2,2,2-trifluroethane |